Results 1 to 10 of about 33,804 (157)
COL1A1::PDGFB fusion-associated uterine sarcoma and response to Imatinib: A case report [PDF]
Gynecologic Oncology Reports, 2023 Uterine sarcomas are rare neoplasms of the uterus, some of which are associated with distinctive gene fusions. COL1A1::PDGFB fusion uterine sarcoma is a recently described entity that shares the same genetic alteration as dermatofibrosarcoma protuberans.
Udita Chapagain +4 more
doaj +2 more sources
Development of a blood test for uterine sarcoma-Diagnosis and monitoring (DOORS-D and DOORS-M) studies. [PDF]
PLoS ONEUterine sarcomas can be difficult to differentiate from uterine fibroids due to many shared symptoms and imaging features, which can result in delayed or missed diagnosis, or over treatment.
Anna Casey +9 more
doaj +2 more sources
Diagnostic and prognostic values of circulating growth differentiation factor-15 and osteopontin in uterine sarcoma [PDF]
Scientific ReportsUterine sarcoma is an aggressive malignancy that is difficult to distinguish from benign leiomyomas pre-operatively. This study aimed to identify circulating biomarkers to improve differential diagnosis and prognostication. The serum and tissue levels of
Hideaki Tsuyoshi +5 more
doaj +2 more sources
Case Report: A case of COL1A1–PDGFB fusion uterine sarcoma at cervix and insights into the clinical management of rare uterine sarcoma [PDF]
Frontiers in Oncology, 2023 COL1A1–PDGFB gene fusion uterine sarcoma is an especially rare malignant mesenchymal tumor that was previously classified as an undifferentiated uterine sarcoma due to the lack of specific features of differentiation.
Linghui Lu +6 more
doaj +2 more sources
Intraperitoneal spread in uterine sarcoma following unprotected laparoscopic transvaginal uterine morcellation: a case report and literature review [PDF]
Frontiers in OncologyClinically and through auxiliary examinations, distinguishing uterine leiomyoma from early-stage uterine sarcoma presents significant challenges. A 48-year-old patient underwent a laparoscopic hysterectomy for uterine leiomyoma, during which a large ...
Jianhao Sun +11 more
doaj +2 more sources
Uterine sarcoma Part II—Uterine endometrial stromal sarcoma: The TAG systematic review
Taiwanese Journal of Obstetrics and Gynecology, 2016 Endometrial stromal tumors are rare uterine tumors (
Huann-Cheng Horng +2 more
exaly +3 more sources
International Journal of Gynecology & Obstetrics, 2015 We bring to the attention of the Peruvian colleagues 2 cases of uterine sarcoma, which recently had at the Clinic headed by Professor JJ Crottogini and we are honored to belong. This is a work of the clinic to which we belong. In addition we tried to collect cases of sarcoma that exist in our environment and we do not know if they are all at least are ...
Prat, Jaime, Mbatani, 'Nomonde
+10 more sources
Clinical and Experimental Obstetrics & Gynecology, 2021 Background: The purpose of this study was to investigate whether the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) can be used as supplemental tools to differentiate between uterine myomas and sarcomas. Methods: From January
Yoon Young Jeong +4 more
doaj +1 more source
Development of an Algorithm to Differentiate Uterine Sarcoma from Fibroids Using MRI and LDH Levels
Diagnostics, 2023 Background: This study aimed to establish an evaluation method for detecting uterine sarcoma with 100% sensitivity using MRI and serum LDH levels. Methods: One evaluator reviewed the MRI images and LDH values of a total of 1801 cases, including 36 cases ...
Ayako Suzuki +11 more
doaj +1 more source
International Journal of Gynecology & Obstetrics, 2018 AbstractUterine sarcomas account for approximately 3%–7% of all uterine cancers. Since carcinosarcomas are currently classified as metaplastic carcinomas, leiomyosarcomas remain the most common subtype. Exclusion of several histologic variants of leiomyoma, as well as atypical smooth muscle tumors (so‐called “smooth muscle tumors of uncertain malignant
Nomonde, Mbatani +2 more
openaire +3 more sources